Alkeus Announces $150 Million Series B Financing, Supporting Rapid Registration Path for gildeuretinol (ALK-001) in the Treatment of Stargardt Disease
Vertex Founder and Industry Pioneer Joshua Boger, Ph.D. named as Executive Chairman of Alkeus CAMBRIDGE,…